Ellen Richmond

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Biomarkers: an overview for oncology nurses
    Ellen S Richmond
    Division of Cancer Prevention, National Cancer Institute, Rockville, MD 20892 7317, USA
    Semin Oncol Nurs 28:87-92. 2012
  2. ncbi Conducting chemoprevention clinical trials: challenges and solutions
    Ellen Richmond
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA
    Semin Oncol 37:402-6. 2010
  3. ncbi Chemoprevention of colorectal carcinogenesis
    Asad Umar
    Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, EPN, Suite 2141, 6130 Executive Boulevard, Bethesda, MD 20892 7317, USA
    Int J Clin Oncol 7:2-26. 2002
  4. ncbi Prevention and therapy of colorectal cancer
    Ernest T Hawk
    Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, EPN, Suite 2141, 6130 Executive Boulevard, Bethesda, MD 20892 7317, USA
    Med Clin North Am 89:85-110, viii. 2005
  5. ncbi Chemoprevention of skin cancer
    Ellen Richmond
    Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, Suite 2141, 6130 Executive Blvd, Bethesda, MD 20892-7317, USA
    Semin Oncol Nurs 19:62-9. 2003
  6. ncbi Non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention
    Ernest T Hawk
    National Cancer Institute, Division of Cancer Prevention, Bethesda, MD 20892-7317, USA
    Cancer Chemother Biol Response Modif 21:759-89. 2003

Detail Information

Publications6

  1. ncbi Biomarkers: an overview for oncology nurses
    Ellen S Richmond
    Division of Cancer Prevention, National Cancer Institute, Rockville, MD 20892 7317, USA
    Semin Oncol Nurs 28:87-92. 2012
    ....
  2. ncbi Conducting chemoprevention clinical trials: challenges and solutions
    Ellen Richmond
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA
    Semin Oncol 37:402-6. 2010
    ..In light of the layer of complexities that chemoprevention research adds to clinical trials, one or more team members need a unique set of skills and knowledge, beyond understanding the scientific aspects of the trial...
  3. ncbi Chemoprevention of colorectal carcinogenesis
    Asad Umar
    Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, EPN, Suite 2141, 6130 Executive Boulevard, Bethesda, MD 20892 7317, USA
    Int J Clin Oncol 7:2-26. 2002
    ..These targets will help identify more effective and better tolerated preventive agents. Carcinogenesis is now recognized as a disease in itself and has become the target of an ever-expanding array of preventive interventions...
  4. ncbi Prevention and therapy of colorectal cancer
    Ernest T Hawk
    Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, EPN, Suite 2141, 6130 Executive Boulevard, Bethesda, MD 20892 7317, USA
    Med Clin North Am 89:85-110, viii. 2005
    ..These advances substantiate target-driven approaches to cancer prevention and treatment, and provide fruitful opportunities for future investigations...
  5. ncbi Chemoprevention of skin cancer
    Ellen Richmond
    Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, Suite 2141, 6130 Executive Blvd, Bethesda, MD 20892-7317, USA
    Semin Oncol Nurs 19:62-9. 2003
    ..Nurses play a role in translational research by bridging the gap between technologic development and patient care...
  6. ncbi Non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention
    Ernest T Hawk
    National Cancer Institute, Division of Cancer Prevention, Bethesda, MD 20892-7317, USA
    Cancer Chemother Biol Response Modif 21:759-89. 2003